Beauty Health Company ( (SKIN) ) has released its Q1 earnings. Here is a breakdown of the information Beauty Health Company presented to its investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The Beauty Health Company, a medtech and beauty firm known for its flagship brand Hydrafacial, specializes in skin health experiences and operates within the beauty industry. In its first quarter of 2025, BeautyHealth reported a decrease in net sales to $69.6 million, a 14.5% drop from the previous year, primarily due to a decline in delivery systems net sales. Despite this, the company achieved a higher gross margin of 69.8% and an adjusted EBITDA of $7.3 million, reflecting improved cost efficiencies and a favorable shift towards consumable sales. The company faced a net loss of $10.1 million, attributed to lower net sales and the absence of gains from prior convertible note repurchases. BeautyHealth is strategically relocating production to the U.S. and transitioning its China operations to a distributor model to enhance profit margins. Looking ahead, the company projects net sales between $270 and $300 million for the fiscal year 2025, with an adjusted EBITDA ranging from $15 to $25 million, as it continues to focus on product launches and brand initiatives to drive long-term growth.